New drug development

被引：2
|
作者：
Catala-Lopez, Ferran [1 ,2 ]
Garcia-Altes, Anna [1 ,3 ]
Alvarez-Martin, Elena [4 ]
Genova-Maleras, Ricard [5 ]
Morant-Ginestar, Consuelo [5 ]
机构：
[1] Fdn Inst Invest Serv Salud, Valencia, Spain
[2] Spanish Med & Healthcare Prod Agcy AEMPS, Madrid, Spain
[3] CAHIAQ, Barcelona, Spain
[4] Rey Juan Carlos Univ, Madrid, Spain
[5] Reg Hlth Council, Madrid, Spain
来源：
LANCET | 2011年 / 377卷 / 9769期
关键词：
D O I：
10.1016/S0140-6736(11)60348-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：902 / 902
页数：1
相关论文
共 50 条
  • [21] Hurdles in the development of a new drug
    Vokes, Everett E.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S301 - S301
  • [22] Acquisition of Drug Candidates in New Drug Development in Japan
    Okuyama, Ryo
    Osada, Hiroshi
    2014 PORTLAND INTERNATIONAL CONFERENCE ON MANAGEMENT OF ENGINEERING & TECHNOLOGY (PICMET), 2014, : 3605 - 3611
  • [23] Drug development - New way to assess drug candidates
    Borman, S
    CHEMICAL & ENGINEERING NEWS, 2002, 80 (23) : 9 - 9
  • [24] Application of drug metabolism and pharmacokinetics for new drug development
    Yoon Gyoon Kim
    Keon Wook Kang
    Archives of Pharmacal Research, 2011, 34 : 1769 - 1771
  • [25] Drug Transporters: Roles in New Drug Discovery and Development
    Sugiyama, Yuichi
    DRUG METABOLISM REVIEWS, 2010, 42 : 1 - 1
  • [26] AUTACOIDS FOR DRUG RECEPTORS - A NEW APPROACH IN DRUG DEVELOPMENT
    BARBACCIA, ML
    COSTA, E
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1984, 430 (JUN) : 103 - 114
  • [27] New Horizons of Model Informed Drug Development in Rare Diseases Drug Development
    Mitra, Amitava
    Tania, Nessy
    Ahmed, Mariam A.
    Rayad, Noha
    Krishna, Rajesh
    Albusaysi, Salwa
    Bakhaidar, Rana
    Shang, Elizabeth
    Burian, Maria
    Martin-Pozo, Michelle
    Younis, Islam R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (06) : 1398 - 1411
  • [28] Clinical Trials in New Drug Development
    Turner, J. Rick.
    Hoofwijk, Theo J.
    JOURNAL OF CLINICAL HYPERTENSION, 2013, 15 (05): : 306 - 309
  • [29] Advantages of toxicokinetics in new drug development
    Horii, I
    TOXICOLOGY LETTERS, 1998, 103 : 657 - 664
  • [30] New Horizons in Pediatric Drug Development
    Spielberg, Stephen P.
    Portman, Ronald
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (05) : 613 - 614
12345